Bio: Cap in Berlin: New investment event for Life Sciences and AI!

Bio: Cap in Berlin: New investment event for Life Sciences and AI!

In the German capital there are exciting news that could significantly shape the future of the health and biotech industry. On June 2 and 3, 2026, the premiere of a new event format called Bio: CAP is planned, which is initiated by the Charité - University Medicine Berlin and the Berlin Institute of Health in the Charité (BIH). This new trade fair aims to network international investors directly with innovative start-ups, research institutions and companies from the areas of biotechnology, techbio and artificial intelligence. According to Charité, the Bio: Cap Investments should attract and promote the technical exchange.

The organizers, which also include Messe Berlin, are actively supported by partners such as the Investment Bank Berlin (IBB) and the investment bank of the State of Brandenburg (ILB). The organic: CAP is viewed as a supplement to the Messe Messe Messe event portfolio and pursues the goal of establishing itself as a leading life science and AI event in Europe.

innovation and networking in focus

What exactly can visitors and exhibitors from the Bio: Cap expect? The event promises top -class content and strategic matchmaking. This includes start-up presentations, research topics and political discussions that address the current challenges of the industry. A special focus will be on the role of artificial intelligence in the Life Sciences. The organizers rely on an open, interactive format that wants to offer both stage presentations and retreats for personal conversations between investors and start-ups.

Berlin itself has established itself as a true start-up capital. With a connection from an entrepreneurial spirit and creative culture, the city attracts talents, capital and creative minds from all over the world. Together with Brandenburg, Berlin has formed an impressive science cluster that produces innovations in biotechnology, AI and digital health. Messe Berlin notes that the most modern tech hubs and a lively nightlife merge in this inspiring backdrop, which promotes openness and exchange.

funding opportunities and support

But not only on stage the organic: cap will provide a fresh wind. The event also serves as a catalyst for investments in the Life Sciences. Here, framework conditions for investors and founders are created and political strategies for science and growth are discussed. The networking of politics with actors from science, investments and pharmaceuticals is a central part of the organic: cap. The event is also seen as a political signal for the positioning of European innovative strength.

In addition, the Bio: Cap offers a platform for data -driven biomedicine and interdisciplinary partnerships. Similar initiatives in the industry, such as the support of Biofo Baden-Württemberg, show how important it is to support founders and founders in the areas of biotechnology, medical technology and pharma. Whether before the foundation or in the first years after the start - accompaniment by experienced coaches and the conveying of contacts to industry are crucial for success.

The Bio: Cap promises to become an exciting event for everyone involved and could lay the foundation for numerous innovative projects. Berlin has established itself as a catalyst for these developments and we can be excited to see what new possibilities will open up through this event.